0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1839247.40%
10Y revenue/share CAGR above 1.5x NHC.AX's 405.53%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
2405.31%
3Y revenue/share CAGR above 1.5x NHC.AX's 105.99%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
185.47%
OCF/share CAGR of 185.47% while NHC.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
144.47%
Below 50% of NHC.AX's 323.58%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
219.67%
3Y OCF/share CAGR under 50% of NHC.AX's 473.50%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
75.04%
Positive 10Y CAGR while NHC.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
95.60%
5Y net income/share CAGR at 50-75% of NHC.AX's 152.08%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-130.58%
Negative 3Y CAGR while NHC.AX is 244.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-94.95%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-78.61%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
240.87%
3Y equity/share CAGR above 1.5x NHC.AX's 1.18%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.